Characterization and Separation of Platinum-Based Antineoplastic Drugs by Zwitterionic Hydrophilic Interaction Liquid Chromatography (HILIC)–Tandem Mass Spectrometry, and Its Application in Surface Wipe Sampling
Authors:
- Stefano DugheriStefano Dugheri
- Nicola MucciNicola Mucci
- Enrico MiniEnrico Mini
- Donato SquillaciDonato Squillaci
- Giorgio MarrubiniGiorgio Marrubini
- Gianluca BartolucciGianluca Bartolucci
- Elisabetta BucalettiElisabetta Bucaletti
- Giovanni CappelliGiovanni Cappelli
- Lucia TrevisaniLucia Trevisani
- Giulio ArcangeliGiulio Arcangeli
Open Access
- 20 May 2021
- journal article
- research article
- Published by MDPI AG in Separations
- Vol. 8 (5) , 69
Abstract
Platinum-based antineoplastic drugs (PtADs) are among the most important and used families of chemotherapy drugs, which, even showing severe side effects and being hindered by drug resistance, are not likely to be replaced clinically any time soon. The growing interest in the occupational health community in antineoplastic drug (AD) surface contamination requires the development of increasingly fast and easy high-throughput monitoring methods, even considering the lack of harmonized legally binding regulation criteria. Thus, a wipe sampling method together with zwitterionic hydrophilic interaction liquid chromatography (HILIC-Z)–tandem mass spectrometry (MS/MS) analysis was developed for the simultaneous evaluation of oxaliplatin, cisplatin, and carboplatin surface contaminations. A design of experiments approach was used to optimize the chromatographic conditions. Limits of quantification ranging from 2 to 5 ng/mL were obtained from interday and intraday repetitions for oxaliplatin and carboplatin, and between 170 and 240 ng/mL for cisplatin. The wipe desorption procedure is equivalent to other AD sampling methods, enabling a fast sample preparation, with an LC-MS/MS analysis time of less than 7 min.Keywords
This publication has 54 references indexed in Scilit:
- Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's DiscoveryJournal of Clinical Oncology, 2015
- Testicular Cancer: A Reflection on 50 Years of DiscoveryJournal of Clinical Oncology, 2014
- Michele Peyrone (1813–1883), Discoverer of CisplatinPlatinum Metals Review, 2010
- The status of platinum anticancer drugs in the clinic and in clinical trialsDalton Transactions, 2010
- Analytical methodologies for metallomics studies of antitumor Pt-containing drugsMetallomics, 2010
- The Discovery and Development of CisplatinJournal of Chemical Education, 2006
- OxaliplatinNature Reviews Drug Discovery, 2004
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965
- Ueber die Einwirkung des Ammoniaks auf PlatinchlorürEuropean Journal of Organic Chemistry, 1844